For example, it uses new technologies, such as laser and infrared sensors, that can analyze potency in every drug product coming down the line.The problem is the amount of data collected in eight million data points, when you had only 10 data points before, says D'Eramo, who is also executive director for worldwide policy and compliance management at Johnson & Johnson (New Brunswick, N.J.).